Svetlana Shulga und Zitiert - Info zur Person

(1 - 6 von 10

)

B Cell-Activating Factor Belonging to the TNF Family Acts ...The American Association of Immunologists

journals.aai.org

von S Shulga-Morskaya · · Zitiert von: 319 — Svetlana Shulga-Morskaya;. Svetlana Shulga-Morskaya. *Biogen Idec, Cambridge, MA ; and. Search for other works by this author on:.

s pdf - NatureNature Journal

www.nature.com

von MM Janas · · Zitiert von: 150 — Ivan Zlatev 1, Adam Castoreno1, Huilei Xu1, Svetlana Shulga-Morskaya1, Kallanthottathil G. Rajeev1,. Muthiah Manoharan1, Natalie D. Keirstead1, ... › articles

5'-triphosphate-siRNA: turning gene silencing and Rig-I GaleGale

go.gale.com

von H Poeck · · Zitiert von: 444 — Authors: Hendrik Poeck, Robert Besch, Cornelius Maihoefer, Marcel Renn, Damia Tormo and Svetlana Shulga Morskaya. Date: Nov › i.do

Effect of an RNA interference drug on the synthesis of ...elsevierpure.com

utsouthwestern.elsevierpure.com

von K Fitzgerald · · Zitiert von: 626 — Kevin Fitzgerald, Maria Frank-Kamenetsky, Svetlana Shulga-Morskaya, Abigail Liebow, Brian R. Bettencourt, Jessica E. Sutherland, Renta M. Hutabarat, ...

Harnessing a physiologic mechanism for siRNA delivery with ...Elsevier

pennstate.pure.elsevier.com

von T Nakayama · · Zitiert von: 77 — Tomoko Nakayama, James S. Butler, Alfica Sehgal, Mariano Severgnini, Tim Racie, Jennifer Sharman, Feng Ding, Svetlana Shulga Morskaya, Joshua Brodsky, ... › ...

Improving the clinical safety of GalNAc-siRNA conjugates ...National Institutes of Health (.gov)

pubmed.ncbi.nlm.nih.gov

von MK Schlegel · Zitiert von: 6 — ... Sarah LeBlanc , Abigail Liebow , Tara Mayo , Stuart Milstein , Tuyen Nguyen , Svetlana Shulga-Morskaya , Sarah Hyde , Sally Schofield ... › ...